The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 10X GENOMICS INC | CL A COM | 88025U109 | 511 | 2,821 | SH | DFND | 0 | 2,821 | 0 | ||
| CROWDSTRIKE HLDGS INC | CL A | 22788C105 | 2,734 | 14,980 | SH | DFND | 0 | 14,980 | 0 | ||
| FINVOLUTION GROUP | SPONSORED ADS | 31810T101 | 180 | 25,737 | SH | DFND | 0 | 25,737 | 0 | ||
| NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 45,737 | 1,573,357 | SH | DFND | 1,573,357 | 0 | 0 | ||
| OBLONG INC | COM | 674434105 | 25,244 | 3,692,661 | SH | DFND | 3,692,661 | 0 | 0 | ||
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 13,557 | 360,939 | SH | DFND | 360,939 | 0 | 0 | ||
| PULMONX CORP | COM | 745848101 | 26 | 566 | SH | DFND | 0 | 566 | 0 | ||
| ROBLOX CORP | CL A | 771049102 | 37,722 | 581,863 | SH | DFND | 581,863 | 0 | 0 | ||